Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.200
+0.130 (4.23%)
At close: Jun 27, 2025

Coegin Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
15.5619.685.553.8225.6616.65
Cash & Short-Term Investments
15.5619.685.553.8225.6616.65
Cash Growth
-15.61%254.70%45.39%-85.13%54.12%-
Other Receivables
0.711.150.643.134.642.5
Receivables
0.711.150.643.134.642.5
Prepaid Expenses
0.170.010.020.020.03-
Other Current Assets
--0----
Total Current Assets
16.4420.846.216.9730.3319.14
Property, Plant & Equipment
0.110.150.30.4900
Other Intangible Assets
5.336.058.9211.79--
Other Long-Term Assets
---10--
Total Assets
21.8827.0415.4329.2530.3419.15
Accounts Payable
0.250.981.7929.731.77
Accrued Expenses
1.550.662.661.710.22-
Current Income Taxes Payable
---0.18--
Other Current Liabilities
0.470.154.244.340.310.66
Total Current Liabilities
2.271.788.688.2310.262.43
Total Liabilities
2.271.788.688.2310.262.43
Common Stock
12.4412.444.735.3327.5723.11
Additional Paid-In Capital
136.19136.2101.694.7666.3841.5
Retained Earnings
-----75.07-47.93
Comprehensive Income & Other
-129.01-123.38-99.54-109.081.20.04
Shareholders' Equity
19.6225.266.7521.0120.0716.71
Total Liabilities & Equity
21.8827.0415.4329.2530.3419.15
Net Cash (Debt)
15.5619.685.553.8225.6616.65
Net Cash Growth
-15.61%254.70%45.39%-85.13%54.12%-
Net Cash Per Share
0.691.040.600.564.3212.74
Filing Date Shares Outstanding
24.8824.889.396.946.941.31
Total Common Shares Outstanding
24.8824.889.396.946.941.31
Working Capital
14.1819.06-2.47-1.2620.0716.71
Book Value Per Share
0.791.020.723.032.8912.79
Tangible Book Value
14.2919.21-2.179.2220.0716.71
Tangible Book Value Per Share
0.570.77-0.231.332.8912.79
Machinery
-0.630.640.680.150.15
Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.